Literature DB >> 23524654

Interaction between natural killer cells and regulatory T cells: perspectives for immunotherapy.

Isabela Pedroza-Pacheco1, Alejandro Madrigal, Aurore Saudemont.   

Abstract

Regulatory T (Treg) cells and natural killer (NK) cells are key players in the immune system. The interaction between these two cell types has been reported to be beneficial in healthy conditions such as pregnancy. However, in the case of certain pathologies such as autoimmune diseases and cancer this interaction can become detrimental, as Treg cells have been described to suppress NK cells and in particular to impair NK cell effector functions. This review aims to discuss the recent information on the interaction between Treg cells and NK cells under healthy and pathologic conditions, to describe the specific conditions in which this interaction takes place, the effect of Treg cells on hematopoietic stem cell differentiation and the consequences of this interaction on the optimization of immunotherapeutic protocols.

Entities:  

Mesh:

Year:  2013        PMID: 23524654      PMCID: PMC4012769          DOI: 10.1038/cmi.2013.2

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  79 in total

1.  Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells.

Authors:  Isabel Barao; Alan M Hanash; William Hallett; Lisbeth A Welniak; Kai Sun; Doug Redelman; Bruce R Blazar; Robert B Levy; William J Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

Review 2.  Control of NK cell functions by CD4+CD25+ regulatory T cells.

Authors:  Natacha Ralainirina; Aurélie Poli; Tatiana Michel; Linda Poos; Emmanuel Andrès; François Hentges; Jacques Zimmer
Journal:  J Leukoc Biol       Date:  2006-09-07       Impact factor: 4.962

3.  Autoreactive T cells mediate NK cell degeneration in autoimmune disease.

Authors:  Ruolan Liu; Luc Van Kaer; Antonio La Cava; Mary Price; Denise I Campagnolo; Mary Collins; Deborah A Young; Timothy L Vollmer; Fu-Dong Shi
Journal:  J Immunol       Date:  2006-05-01       Impact factor: 5.422

Review 4.  Reciprocal regulation between natural killer cells and autoreactive T cells.

Authors:  Fu-Dong Shi; Luc Van Kaer
Journal:  Nat Rev Immunol       Date:  2006-10       Impact factor: 53.106

5.  Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients.

Authors:  François Ghiringhelli; Cedric Menard; Pierre Emmanuel Puig; Sylvain Ladoire; Stephan Roux; François Martin; Eric Solary; Axel Le Cesne; Laurence Zitvogel; Bruno Chauffert
Journal:  Cancer Immunol Immunother       Date:  2006-09-08       Impact factor: 6.968

6.  CD25+CD4+ regulatory T cells and memory T cells prevent lymphopenia-induced proliferation of naive T cells in transient states of lymphopenia.

Authors:  Christine Bourgeois; Brigitta Stockinger
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

7.  Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.

Authors:  Emilie Brillard; Jean-René Pallandre; David Chalmers; Bernhard Ryffel; Amandine Radlovic; Estelle Seilles; Pierre Simon Rohrlich; Xavier Pivot; Pierre Tiberghien; Philippe Saas; Christophe Borg
Journal:  Exp Hematol       Date:  2007-03       Impact factor: 3.084

8.  CD4+ regulatory T cells are spared from deletion by antilymphocyte serum, a polyclonal anti-T cell antibody.

Authors:  Keisuke Minamimura; Wenda Gao; Takashi Maki
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

9.  Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells.

Authors:  Marina I Garín; Chung-Ching Chu; Dela Golshayan; Eva Cernuda-Morollón; Robin Wait; Robert I Lechler
Journal:  Blood       Date:  2006-11-16       Impact factor: 22.113

10.  Regulatory T cells inhibit Fas ligand-induced innate and adaptive tumour immunity.

Authors:  Anna Katharina Simon; Emma Jones; Hannah Richards; Kate Wright; Gareth Betts; Andrew Godkin; Gavin Screaton; Awen Gallimore
Journal:  Eur J Immunol       Date:  2007-03       Impact factor: 5.532

View more
  56 in total

1.  Intravenous immunoglobulin exerts reciprocal regulation of Th1/Th17 cells and regulatory T cells in Guillain-Barré syndrome patients.

Authors:  Mohan S Maddur; Magalie Rabin; Pushpa Hegde; Francis Bolgert; Moneger Guy; Jean-Michel Vallat; Laurent Magy; Jagadeesh Bayry; Srini V Kaveri
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

2.  Association of peripheral NK cell counts with Helios+ IFN-γ- Tregs in patients with good long-term renal allograft function.

Authors:  K Trojan; L Zhu; M Aly; R Weimer; N Bulut; C Morath; G Opelz; V Daniel
Journal:  Clin Exp Immunol       Date:  2017-03-13       Impact factor: 4.330

3.  Intratumoral natural killer cells show reduced effector and cytolytic properties and control the differentiation of effector Th1 cells.

Authors:  Sourav Paul; Neeraja Kulkarni; Girdhari Lal
Journal:  Oncoimmunology       Date:  2016-09-20       Impact factor: 8.110

4.  Frontiers in natural killer cell immunology.

Authors:  Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2013-05-04       Impact factor: 11.530

5.  Deletion of Fanca or Fancd2 dysregulates Treg in mice.

Authors:  Wei Du; Ozlem Erden; Andrew Wilson; Jared M Sipple; Jonathan Schick; Parinda Mehta; Kasiani C Myers; Kris A Steinbrecher; Stella M Davies; Qishen Pang
Journal:  Blood       Date:  2014-02-05       Impact factor: 22.113

6.  Targeting CD38 Suppresses Induction and Function of T Regulatory Cells to Mitigate Immunosuppression in Multiple Myeloma.

Authors:  Xiaoyan Feng; Li Zhang; Chirag Acharya; Gang An; Kenneth Wen; Lugui Qiu; Nikhil C Munshi; Yu-Tzu Tai; Kenneth C Anderson
Journal:  Clin Cancer Res       Date:  2017-03-01       Impact factor: 12.531

Review 7.  Natural killer cells and regulatory T cells: how to manipulate a graft for optimal GVL.

Authors:  Michael R Verneris
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2013

8.  Natural Killer Cell Homing and Persistence in the Bone Marrow After Adoptive Immunotherapy Correlates With Better Leukemia Control.

Authors:  Bartosz Grzywacz; Laura Moench; David McKenna; Katelyn M Tessier; Veronika Bachanova; Sarah Cooley; Jeffrey S Miller; Elizabeth L Courville
Journal:  J Immunother       Date:  2019 Feb/Mar       Impact factor: 4.456

9.  Pseudomonas aeruginosa Infection Impairs NKG2D-Dependent NK Cell Cytotoxicity through Regulatory T-Cell Activation.

Authors:  Mickael Vourc'h; Gaelle David; Benjamin Gaborit; Alexis Broquet; Cedric Jacqueline; Tanguy Chaumette; Jocelyne Caillon; Antoine Roquilly; Christelle Retiere; Karim Asehnoune
Journal:  Infect Immun       Date:  2020-11-16       Impact factor: 3.441

Review 10.  Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy.

Authors:  Zachary B Davis; Daniel A Vallera; Jeffrey S Miller; Martin Felices
Journal:  Semin Immunol       Date:  2017-09-05       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.